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Postural orthostatic tachycardia syndrome (POTS) commonly aﬀects women of childbearing age. We report on a 37-year-old
woman who developed symptoms of recurrent syncope in the postpartum period. Her head up tilt test and clinical presentation
was consistent with POTS.
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1.Introduction
Recurrent unexpected syncope may have severe conse-
quences and can result in serious injury, especially in a
postpartum period when the maternal syncope can have the
disastrous eﬀect on the newborn infant as well as the mother.
Postpartum syncope has been reported to result in death due
to dropping of the infants [1]. We report on a 37-year-old
woman who developed recurrent episodes of syncope in the
postpartum period.
2.Case
A37-year-oldwomanwithapastmedicalhistoryofmigraine
headache and reﬂux esophagitis was seen in our autonomic
clinic for evaluation of recurrent syncope. In the last nine
years, she had experienced episodes of debilitating recurrent
syncope. Her ﬁrst episode occurred six months after she
gave birth to her daughter. At that time, she described
an episode that occurred while standing at work during
which she became “fuzzy”, lightheaded, and subsequently
suﬀered from an episode of syncope with a brief loss of
consciousness. She had no convulsive activity during this
episode. She continued to experience episodes of lighthead-
ednesswithoutfranksyncope.Sixyearsafterherﬁrstepisode
the symptoms and the frequency of episodes progressed
to the point where she experienced approximately eight
episodes of lightheadedness and palpitations over a period
of six months, occasionally resulting in syncope. In the
interim, multiple neurologists evaluated her. Ultimately, a
cardiologist sent her for head up tilt test (HUTT). Upon the
assumption of upright posture during the tilt test, her heart
rate increased from 86 beats per minute (bpm) (baseline) to
126bpm within 5 minutes, and her blood pressure dropped
from 126mmHg (baseline) to 90mmHg, associated with
symptoms of lightheadedness, palpitations and loss of con-
sciousness. She was initially treated with ﬂudrocortisone,
which failed to relieve her symptoms. Midodrine (an alpha
agonist) and methylphenidate (noncatecholamine sympa-
thomimetic) were also tried but ineﬀective. She suﬀered
multiple injuries (including head injuries) during these
episodes of syncope, and her quality of life had markedly
decreased. During one traumatic syncopal episode, she
fell while attending physical therapy. In addition, she also
suﬀered from loss of memory and balance problems.
In our clinic, she presented with a blood pressure of
100/80 sitting and 90/64 standing. Her supine heart rate was
70 beats per minute and immediately upon standing rose to
111 beats per minute. The rest of the physical examination
was normal except for the presence of joint hypermobility in
thebilateralwrists,thumbs,ﬁngers,elbows,andankles.After
review of her history, physical exam, and the extensive evalu-
ation, the diagnostic impression was autonomic dysfunction
and orthostatic intolerance most consistent with new onset
postpartum postural orthostatic tachycardia syndrome. Her
overall clinical picture of orthostatic intolerance and joint
ﬁndings were most consistent with joint hypermobility.2 Cardiology Research and Practice
The initial core management choices here were reasonable;
indeed the prior management was essentially exactly as our
center would recommend.
She was commenced on Duloxetine, a serotonin/
norepinephrine reuptake inhibitor. During her next clinic
visit, she reported marked improvement in symptoms,
except for headache and mild cognitive impairment. She was
started on Cerefolin to help the memory loss [2].
3. Discussion
Multiplecardiovascularadaptationsoccurduringpregnancy,
which are essential for successful completion of pregnancy.
These include an increase in cardiac output, sodium, and
water retention with increase in expansion of blood volume
and a reduction in peripheral vascular resistance and dias-
tolic blood pressure [3]. These cardiovascular adaptations
continue in the postpartum period and allow for return to a
nonpregnant state. These changes in the postpartum period
have not been well reported or studied [4]. Our patient
developed recurrent episodes of syncope in the postpar-
tum period. Postpartum syncope with signiﬁcant maternal
morbidity and one infant mortality has been reported
previously [1]. There have been reports that patients with
POTS can have a favorable outcome during pregnancy
and in postpartum period [5, 6]. The joint hypermobility
syndrome might have predisposed our patient to symptoms
of orthostatic intolerance and made her vulnerable especially
as she returned to the prepregnant state with gradual loss
of estrogen/progesterone, induced ﬂuid retention in the
postpartum period.
In patients with POTS, the main mechanism is the con-
sistent failure of the peripheral vascular system to increase
resistance during upright posture. Patients with joint hyper-
mobility syndrome even have more diﬃculty owing to loss
of supporting connective tissues in the vessels. Orthostatic
intolerance develops in these patients due to the presence
of abnormally elastic connective tissue in the vasculature.
This results in an increase in vessel distensibility in response
to the augmented hydrostatic pressure that occurs during
orthostatic stress. Consequently, there is excessive peripheral
venous pooling with a resultant compensatory tachycardia.
About 70% of patients with hypermobility syndrome may
suﬀer from some form of orthostatic intolerance due to
sympathetic dys-regulation [7]. Patients with POTS can
present with syncope without a substantial fall in blood
pressure. Increase in cerebrovascular resistance occurring
during orthostatic stress can explain loss of consciousness in
these patients [8].
These patients are usually treated with ﬂudrocortisone
[9] midodrine [10], methylphenidate [11], and selective
serotonin reuptake inhibitors [12, 13]. Combined selective
serotonin reuptake inhibitors and selective norepinephrine
reuptake inhibitors such as duloxetine are most eﬀective.
Duloxetine is postulated to alter serotonin receptor density
in brainstem area and thus alter autonomic tone.
In our experience, we have found that use of combined
selective serotonin reuptake inhibitors and selective nore-
pinephrine reuptake inhibitors has been more eﬀective in
POTS than in neurocardiogenic syncope [14].
4. Conclusion
POTS in the postpartum period can have serious conse-
quences; indeed the risks associated with syncope can be life
threatening not only to mother but also to the child as well.
Early recognition and proper management of these patients
are essential to prevent serious morbidity and mortality
associated with this clinical entity. Long-term outcomes in
patients with postpartum POTS are unknown.
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